Viewing StudyNCT01621724



Ignite Creation Date: 2024-05-06 @ 12:39 AM
Last Modification Date: 2024-10-26 @ 10:52 AM
Study NCT ID: NCT01621724
Status: COMPLETED
Last Update Posted: 2018-10-02
First Post: 2012-03-22

Brief Title: WT1 TCR Gene Therapy for Leukaemia A Phase III Safety and Toxicity Study
Sponsor: Cell Medica Ltd
Organization: Cell Medica Ltd

Conditions & Keywords Data

Conditions:
Name
Chronic Myeloid Leukaemia
Acute Myeloid Leukaemia
Keywords:
Name View
CML View
Gene therapy View
WT1 TCR View
AML View